Arsenal Medical

medical devices

About

Arsenal Medical is a biomedical company dedicated to designing and developing innovative biomaterials and medical devices. The company focuses on addressing critical unmet medical needs, particularly in trauma and embolic therapies. Founded by Carmichael Roberts, Robert Langer, and George Whitesides, Arsenal Medical utilizes expertise in materials science, chemistry, and engineering to create unique biomaterials specifically for clinical applications. Under the leadership of President and CEO Dr. Upma Sharma, Arsenal Medical has developed a proprietary biomaterial platform and advanced two clinical-stage products: ResQFoam™, a hemorrhage control device with FDA breakthrough device status, and NeoCast™, which has completed a First-in-Human clinical study. The company has received over $65 million in funding from notable sources, including the Department of Defense and NIH. Arsenal Medical targets healthcare providers involved in trauma care and vascular medicine, aiming to improve patient outcomes in critical situations.

Technologies

Cloudflare DNS CloudFlare Hosting Google Tag Manager WordPress.org Mobile Friendly jPlayer Google Maps (Non Paid Users) Google Maps Remote IoT AI

Keywords

biomaterials local therapy device development microvasculature penetration emergency medical devices patents injectable biomaterials life-saving trauma treatment clinical development vascular occlusion liquid embolic b2b targeted vascular occlusion target vessel penetration biotechnology medical devices clinical trials neurovascular occlusion neurovascular embolization neurovascular conditions vascular embolization shear-responsive materials trauma hemorrhage injectable materials healthcare trauma treatment medical equipment and supplies manufacturing device engineering life-threatening trauma medical technology

Location

100 Beaver Street, Waltham, Massachusetts, United States, 02453

Related Companies

Companies in the same industry